These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31798904)

  • 1. Deficiency of C3a receptor attenuates the development of diabetic nephropathy.
    Li XQ; Chang DY; Chen M; Zhao MH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000817. PubMed ID: 31798904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a receptor blockade protects podocytes from injury in diabetic nephropathy.
    Morigi M; Perico L; Corna D; Locatelli M; Cassis P; Carminati CE; Bolognini S; Zoja C; Remuzzi G; Benigni A; Buelli S
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32161193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway.
    Li L; Yin Q; Tang X; Bai L; Zhang J; Gou S; Zhu H; Cheng J; Fu P; Liu F
    PLoS One; 2014; 9(11):e113639. PubMed ID: 25422985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complement C3a receptor is critical in defense against Chlamydia psittaci in mouse lung infection and required for antibody and optimal T cell response.
    Dutow P; Fehlhaber B; Bode J; Laudeley R; Rheinheimer C; Glage S; Wetsel RA; Pabst O; Klos A
    J Infect Dis; 2014 Apr; 209(8):1269-78. PubMed ID: 24273177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein inhibits C3a/C3aR-dependent podocyte autophagy in favor of diabetic kidney disease.
    Zhang L; Li W; Gong M; Zhang Z; Xue X; Mao J; Zhang H; Li S; Liu X; Wu F; Shi J; Fu G
    FASEB J; 2022 Jun; 36(6):e22332. PubMed ID: 35503088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
    Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
    Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
    Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
    J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.
    Li Z; Li Y; Overstreet JM; Chung S; Niu A; Fan X; Wang S; Wang Y; Zhang MZ; Harris RC
    Diabetes; 2018 Sep; 67(9):1847-1857. PubMed ID: 29959129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.
    Lim AK; Ma FY; Nikolic-Paterson DJ; Kitching AR; Thomas MC; Tesch GH
    Diabetologia; 2010 Aug; 53(8):1772-82. PubMed ID: 20422398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human T lymphocytes express a functional C3a receptor.
    Werfel T; Kirchhoff K; Wittmann M; Begemann G; Kapp A; Heidenreich F; Götze O; Zwirner J
    J Immunol; 2000 Dec; 165(11):6599-605. PubMed ID: 11086104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
    Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
    Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing.
    Wysoczynski M; Reca R; Lee H; Wu W; Ratajczak J; Ratajczak MZ
    Leukemia; 2009 Aug; 23(8):1455-61. PubMed ID: 19357704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.
    Kim KH; Hong GL; Jung DY; Karunasagara S; Jeong WI; Jung JY
    Mol Med; 2021 Mar; 27(1):25. PubMed ID: 33691614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complement C3a and C3a Receptor Pathway in Kidney Diseases.
    Gao S; Cui Z; Zhao MH
    Front Immunol; 2020; 11():1875. PubMed ID: 32973774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in dextran sulfate sodium (DSS)-induced colitis in mice.
    Wende E; Laudeley R; Bleich A; Bleich E; Wetsel RA; Glage S; Klos A
    PLoS One; 2013; 8(4):e62257. PubMed ID: 23638016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice.
    Wu KY; Zhang T; Zhao GX; Ma N; Zhao SJ; Wang N; Wang JX; Li ZF; Zhou W; Li K
    Kidney Int; 2019 Sep; 96(3):612-627. PubMed ID: 31133456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Complement C3a Receptor in Stroke.
    Ahmad S; Bhatia K; Kindelin A; Ducruet AF
    Neuromolecular Med; 2019 Dec; 21(4):467-473. PubMed ID: 31102134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.